Market Price

24.91 

5.55 28.7%

as of Aug 22 '19

52 Week Range:

17.74 40.10


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

NMC Health Plc provides healthcare services in the United Arab Emirates, the United Kingdom, Spain, and internationally. The company operates through two segments, Healthcare, and Distribution & Services. It owns and manages approximately 200 healthcare facilities, including hospitals, medical centers, long term care facilities, day surgery centers, fertility clinics, and home health services providers. The company offers medical services comprising diagnostic, and in and outpatient services, as well as research and medical services in the field of gynecology, obstetrics, and human reproduction; and management services in respect of hospitals, as well as retails pharmaceutical goods. It also trades in pharmaceutical goods, medical equipment, cosmetics, and food products. NMC Health Plc was founded in 1975 and is based in London, the United Kingdom.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Equity (BVPS) 0.31
0.35
0.34
1.10
1.14
1.43
1.62
2.14
3.57
4.44
growth rate 12.9% -2.9% 223.5% 3.6% 25.4% 13.3% 32.1% 66.8% 24.4%
Earnings BIT 5.03
14.63
26.94
36.79
83.28
88.41
115.02
190.08
282.50
380.59
growth rate 190.9% 84.1% 36.6% 126.3% 6.2% 30.1% 65.3% 48.6% 34.7%
Avg.PE 9.28
19.69
14.13
25.61
25.87
38.91
27.59
growth rate 112.2% -28.2% 81.3% 1.0% 50.4% -29.1%
ROA 1.98
5.26
11.12
11.00
8.91
8.67
6.84
7.04
7.08
7.30
growth rate 165.7% 111.4% -1.1% -19.0% -2.7% -21.1% 2.9% 0.6% 3.1%
ROE 8.48
22.06
42.84
27.46
19.04
18.33
17.55
19.03
18.63
20.78
growth rate 160.1% 94.2% -35.9% -30.7% -3.7% -4.3% 8.4% -2.1% 11.5%
ROIC 7.12
10.95
19.17
14.55
11.41
11.05
9.74
10.26
10.65
12.27
growth rate 53.8% 75.1% -24.1% -21.6% -3.2% -11.9% 5.3% 3.8% 15.2%
Cur. Ratio 0.97
0.88
1.26
2.02
2.13
1.56
1.50
1.74
1.60
1.45
growth rate -9.3% 43.2% 60.3% 5.5% -26.8% -3.9% 16.0% -8.1% -9.4%
Quick Ratio 0.66
0.69
0.97
1.67
1.61
1.18
1.09
1.34
1.24
1.14
growth rate 4.6% 40.6% 72.2% -3.6% -26.7% -7.6% 22.9% -7.5% -8.1%
Leverage 4.28
4.12
3.58
2.17
2.11
2.12
2.98
2.55
2.70
2.97
growth rate -3.7% -13.1% -39.4% -2.8% 0.5% 40.6% -14.4% 5.9% 10.0%
Balance Sheet Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Acct.Receivable 46.91
182.00
146.00
178.00
171.79
191.80
274.53
365.92
534.98
622.16
growth rate 288.0% -19.8% 21.9% -3.5% 11.7% 43.1% 33.3% 46.2% 16.3%
Acct.Payable 59.00
48.00
53.00
62.58
86.29
104.45
123.08
181.28
247.86
growth rate -18.6% 10.4% 18.1% 37.9% 21.1% 17.8% 47.3% 36.7%
Cur.Assets 131.18
253.00
262.00
513.00
540.45
577.93
604.26
1,147.91
1,128.50
1,391.49
growth rate 92.9% 3.6% 95.8% 5.4% 6.9% 4.6% 90.0% -1.7% 23.3%
Total Assets 236.58
418.00
357.00
716.00
815.26
950.53
1,453.88
2,316.99
2,939.01
3,872.42
growth rate 76.7% -14.6% 100.6% 13.9% 16.6% 53.0% 59.4% 26.9% 31.8%
Cash 6.46
16.00
43.00
24.00
75.33
79.59
122.30
589.51
318.53
378.27
growth rate 147.5% 168.8% -44.2% 213.9% 5.7% 53.7% 382.0% -46.0% 18.8%
Inventory 30.90
49.00
54.00
72.00
94.12
110.21
134.79
144.39
181.33
247.31
growth rate 58.6% 10.2% 33.3% 30.7% 17.1% 22.3% 7.1% 25.6% 36.4%
Cur.Liabilities 135.31
287.00
212.00
256.00
253.82
370.57
402.34
660.16
703.76
960.06
growth rate 112.1% -26.1% 20.8% -0.9% 46.0% 8.6% 64.1% 6.6% 36.4%
Liabilities 181.23
315.00
256.00
384.00
426.11
497.50
954.22
1,368.12
1,794.38
2,515.65
growth rate 73.8% -18.7% 50.0% 11.0% 16.8% 91.8% 43.4% 31.2% 40.2%
LT Debt 41.18
20.00
35.00
118.00
161.85
114.46
483.73
594.78
987.84
1,443.84
growth rate -51.4% 75.0% 237.1% 37.2% -29.3% 322.6% 23.0% 66.1% 46.2%
Equity 55.96
63.41
61.74
204.13
386.24
449.02
487.70
906.87
1,089.72
1,303.78
growth rate 13.3% -2.6% 230.6% 89.2% 16.3% 8.6% 86.0% 20.2% 19.6%
Common Shares 130.00
130.00
130.00
172.00
186.00
186.00
29.57
31.91
31.93
32.44
growth rate 0.0% 0.0% 32.3% 8.1% 0.0% -84.1% 7.9% 0.1% 1.6%
Cash Flow Statement Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Capital Expenditures 20.87
18.00
20.00
105.00
78.62
111.25
79.28
59.57
63.45
160.63
growth rate -13.8% 11.1% 425.0% -25.1% 41.5% -28.7% -24.9% 6.5% 153.2%
Cash Dividends 0.00
0.00
0.00
0.00
11.60
13.85
15.87
16.35
27.78
35.74
growth rate 19.4% 14.6% 3.1% 69.9% 28.7%
Cash From OA 37.31
36.00
71.00
35.00
85.07
85.68
84.08
176.37
277.51
387.82
growth rate -3.5% 97.2% -50.7% 143.1% 0.7% -1.9% 109.8% 57.4% 39.8%
FCF per Share -0.24
-0.17
-0.04
-0.11
0.30
0.55
0.62
growth rate 0.0% 0.0% 0.0% 100.0% 83.3% 12.7%
Sale Purchase of Stock 322.31
322.31
322.31
322.31
growth rate 0.0% 0.0% 0.0%
FCF 23.00
6.00
51.00
-67.00
6.00
-26.00
4.00
116.00
213.00
223.00
growth rate -73.9% 750.0% -100.0% 100.0% -100.0% 100.0% 2,800.0% 83.6% 4.7%
Income Statement Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Sales 208.63
387.00
444.00
490.00
550.88
643.93
880.87
1,220.84
1,603.40
2,057.25
growth rate 85.5% 14.7% 10.4% 12.4% 16.9% 36.8% 38.6% 31.3% 28.3%
Op.Income 12.03
24.00
44.00
60.00
83.28
88.41
115.02
190.08
282.50
380.59
growth rate 99.5% 83.3% 36.4% 38.8% 6.2% 30.1% 65.3% 48.6% 34.7%
IBT 5.05
14.65
26.96
36.81
69.14
77.53
85.36
151.58
210.43
256.85
growth rate 190.3% 84.0% 36.5% 87.8% 12.1% 10.1% 77.6% 38.8% 22.1%
Net Income 4.68
24.00
44.00
60.00
68.17
76.57
82.22
132.69
185.97
248.65
growth rate 413.0% 83.3% 36.4% 13.6% 12.3% 7.4% 61.4% 40.2% 33.7%
EPS 0.14
0.38
0.33
0.34
0.36
0.41
0.44
0.70
0.90
1.18
growth rate 171.4% -13.2% 3.0% 5.9% 13.9% 7.3% 59.1% 28.6% 31.1%
Gross Profit 63.16
119.00
137.00
160.00
185.54
209.21
304.94
467.51
635.35
841.13
growth rate 88.4% 15.1% 16.8% 16.0% 12.8% 45.8% 53.3% 35.9% 32.4%

Quarterly Statements

Item Name Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Earnings BIT 73.58
91.07
91.07
99.22
99.22
growth rate 23.8% 0.0% 9.0% 0.0%
Balance Sheet Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Acct.Receivable 530.93
653.68
653.68
622.16
622.16
growth rate 23.1% 0.0% -4.8% 0.0%
Acct.Payable 181.28
266.53
266.53
247.86
247.86
growth rate 47.0% 0.0% -7.0% 0.0%
Cur.Assets 1,128.50
1,328.90
1,328.90
1,391.49
1,391.49
growth rate 17.8% 0.0% 4.7% 0.0%
Total Assets 2,939.01
3,632.93
3,632.93
3,872.42
3,872.42
growth rate 23.6% 0.0% 6.6% 0.0%
Cash 318.53
404.58
404.58
378.27
378.27
growth rate 27.0% 0.0% -6.5% 0.0%
Inventory 181.33
208.64
208.64
247.31
247.31
growth rate 15.1% 0.0% 18.5% 0.0%
Cur.Liabilities 703.76
836.98
836.98
960.06
960.06
growth rate 18.9% 0.0% 14.7% 0.0%
Liabilities 1,794.38
2,421.38
2,421.38
2,515.65
2,515.65
growth rate 34.9% 0.0% 3.9% 0.0%
LT Debt 987.84
1,493.19
1,493.19
1,443.84
1,443.84
growth rate 51.2% 0.0% -3.3% 0.0%
Equity 1,089.72
1,172.87
1,172.87
1,303.78
1,303.78
growth rate 7.6% 0.0% 11.2% 0.0%
Common Shares 31.93
32.44
32.44
32.44
32.44
growth rate 1.6% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Capital Expenditures 20.27
26.37
26.37
53.95
53.95
growth rate 30.1% 0.0% 104.6% 0.0%
Cash Dividends 17.87
17.87
17.87
17.87
growth rate 0.0% 0.0% 0.0%
Cash From OA 91.33
39.79
39.79
154.12
154.12
growth rate -56.4% 0.0% 287.4% 0.0%
Sale Purchase of Stock
growth rate
FCF 71.06
13.42
13.42
100.18
100.18
growth rate -81.1% 0.0% 646.5% 0.0%
Income Statement Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Sales 414.12
465.99
465.99
562.64
562.64
growth rate 12.5% 0.0% 20.7% 0.0%
Op.Income 73.58
91.07
91.07
99.22
99.22
growth rate 23.8% 0.0% 9.0% 0.0%
IBT 55.56
59.36
59.36
69.07
69.07
growth rate 6.8% 0.0% 16.4% 0.0%
Net Income 49.12
58.25
58.25
66.08
66.08
growth rate 18.6% 0.0% 13.5% 0.0%
Gross Profit 165.24
188.24
188.24
232.33
232.33
growth rate 13.9% 0.0% 23.4% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

A+ (97.05)

YOY Growth Grade:

B (72.60)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 15.58 20.97 10.62
EPS / Growth 25.1% 1.19 31.6%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 35.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 25.1% 30.6% 30.6%
Future PE 10.62 13.93 29.11
Future EPS 11.11 17.10 17.10
Value Price
MOS %
29.16
17.0%
58.85
136.3%
123.01
393.8%
MOS Price 14.58 29.43 61.50
IRT 7.35 6.63 6.63

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.